Visual signs and symptoms of Parkinson's disease
暂无分享,去创建一个
[1] C. Evinger,et al. Aging of the trigeminal blink system , 2001, Experimental Brain Research.
[2] T. Paolo,et al. The retinal dopamine system in Parkinson's disease , 1993 .
[3] J. Jankovic,et al. Neuro-ophthalmic findings in progressive supranuclear palsy. , 1992, Journal of clinical neuro-ophthalmology.
[4] Houeto Jean-Luc. [Parkinson's disease]. , 2022, La Revue du praticien.
[5] W. Kuhn,et al. Effects of apomorphine on visual functions in Parkinson's disease , 2000, Journal of Neural Transmission.
[6] M. B. Bender,et al. Oculomotor function in patients with Parkinson's disease. , 1972, Journal of the neurological sciences.
[7] W. J. Graham,et al. Dequalinium in Myasthenia Gravis , 1959, British medical journal.
[8] P. Nunn,et al. Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. , 1987, Science.
[9] H. Przuntek,et al. Loss of visual acuity under dopamine substitution therapy , 2000 .
[10] W. Sippell,et al. Long-Term Follow-Up of Spontaneous Development in a Boy with Familial Male Precocious Puberty , 2004, Hormone Research in Paediatrics.
[11] J. Langston,et al. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. , 1983, Science.
[12] M. Yahr,et al. Visual dysfunction in Parkinson's disease. Loss in spatiotemporal contrast sensitivity. , 1987, Brain : a journal of neurology.
[13] K. Mewes,et al. Visual fields in patients with posterior GPi pallidotomy , 1998, Neurology.
[14] Jennifer J. Pokorny,et al. Activity of substantia nigra pars reticulata neurons during smooth pursuit eye movements in monkeys , 2005, The European journal of neuroscience.
[15] A. Lang,et al. Interface between tauopathies and synucleinopathies: A tale of two proteins , 2006, Annals of neurology.
[16] Nigel J. Cairns,et al. Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies , 1998, Neuroscience Letters.
[17] J. Friedman. Ophthalmologic features of Parkinson's disease. , 2004, Neurology.
[18] A. Cronin-Golomb,et al. Visual and spatial symptoms in Parkinson’s disease , 2005, Vision Research.
[19] M. Hankins,et al. Neurobiology of retinal dopamine in relation to degenerative states of the tissue , 1997, Vision Research.
[20] Andreas U Bayer,et al. Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson's disease. , 2002, American journal of ophthalmology.
[21] M. Yahr,et al. Measurements of visual evoked potentials in Parkinson's disease. , 1978, Brain : a journal of neurology.
[22] R. Carpenter,et al. Saccadic latency distributions in Parkinson’s disease and the effects of l-dopa , 2006, Experimental Brain Research.
[23] F. Lepore. Parkinson's Disease and Diplopia , 2006 .
[24] P. Fitzgerald,et al. Self-paced saccades and saccades to oddball targets in Parkinson's disease , 2006, Brain Research.
[25] I. Gottlob,et al. Alteration of visual evoked potentials and electroretinograms in Parkinson's disease. , 1987, Electroencephalography and clinical neurophysiology.
[26] George W. Bruyn,et al. Brain's diseases of the nervous system , 1969 .
[27] E. Neumann,et al. Benzhexol-induced blindness in Parkinson's disease. , 1972, British medical journal.
[28] G. Stebbins,et al. Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: Focused review and a new integrative model , 2005, Movement disorders : official journal of the Movement Disorder Society.
[29] A. Laties,et al. Dopaminergic neurons in the human retina , 1982, The Journal of comparative neurology.
[30] Peter J. Lang,et al. A Bio‐Informational Theory of Emotional Imagery , 1979 .
[31] T. Mauger,et al. Cholinergic sensitivity of irides from donors with various pathological conditions and lens implants , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.
[32] G. Trick,et al. Visual Impairment in Parkinson's Disease: Deficits in Orientation and Motion Discrimination , 1994, Optometry and vision science : official publication of the American Academy of Optometry.
[33] T. Horiuchi,et al. Desmoplastic fibroma of the calvarium , 1998, Journal of clinical neuroscience.
[34] R. Armstrong,et al. Alzheimer's disease and the eye , 1996, Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians.
[35] R A Crowther,et al. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. , 1998, Neuroscience letters.
[36] Eye movements in Parkinson's disease: before and after pallidotomy. , 2000, Investigative ophthalmology & visual science.
[37] P. Silburn,et al. Prevalence of Parkinson’s disease in metropolitan and rural Queensland: A general practice survey , 2006, Journal of Clinical Neuroscience.
[38] G. Bernardi,et al. Visual alterations in de novo Parkinson's disease , 1995, Neurology.
[39] K. Heilman,et al. Emotional facial imagery, perception, and expression in Parkinson's disease , 1995, Neurology.
[40] J. Elias,et al. Levodopa improves spatial contrast sensitivity in Parkinson's disease. , 1993, Archives of neurology.
[41] Fractionation of visuoperceptual dysfunction in Parkinson's disease , 1995, Journal of the Neurological Sciences.
[42] M. Repka,et al. Ocular motility in Parkinson's disease. , 1996, Journal of pediatric ophthalmology and strabismus.
[43] G R Barnes,et al. Progressive bradykinesia and hypokinesia of ocular pursuit in Parkinson’s disease , 1999, Journal of neurology, neurosurgery, and psychiatry.
[44] Richard D. Jones,et al. Impairment of high‐contrast visual acuity in Parkinson's disease , 1992, Movement disorders : official journal of the Movement Disorder Society.
[45] A. H. Kadish,et al. Vision loss associated with amantadine hydrochloride use. , 1977, JAMA.
[46] L. Hunt,et al. Review of the visual system in Parkinson's disease. , 1995, Optometry and vision science : official publication of the American Academy of Optometry.
[47] C. Bulens,et al. Effect of levodopa treatment on contrast sensitivity in Parkinson's disease , 1987, Annals of Neurology.
[48] L. Henderson,et al. Predictive responses in Parkinson's disease: manual keypresses and saccadic eye movements to regular stimulus events. , 1989, Journal of neurology, neurosurgery, and psychiatry.
[49] L. Murri,et al. Chromatic pattern-reversal electroretinograms (ChPERGs) are spared in multiple system atrophy compared with Parkinson’s disease , 2006, Neurological Sciences.
[50] Colour discrimination impairment is not a reliable early marker of Parkinson's disease , 2001, Journal of Neurology.
[51] G. Nappi,et al. Disordered pupil reactivity in Parkinson's disease , 1991, Clinical Autonomic Research.
[52] M. Breteler,et al. Epidemiology of Parkinson's disease , 2006, The Lancet Neurology.
[53] William J. Jagust,et al. Cortical glucose metabolism in Parkinson's disease without dementia , 1994, Neurobiology of Aging.
[54] P. Jurák,et al. The effect of apomorphine administration on smooth pursuit ocular movements in early Parkinsonian patients. , 2003, Parkinsonism & related disorders.
[55] C. Figarella,et al. Developmental Gene Expression and Immunohistochemical Study of the Human Endocrine Pancreas during Fetal Life , 1998, Hormone Research in Paediatrics.
[56] R. Leigh,et al. Whipple’s disease mimicking progressive supranuclear palsy: the diagnostic value of eye movement recording , 1999, Journal of neurology, neurosurgery, and psychiatry.
[57] W. Weiner,et al. Visuospatial impairment in Parkinson's disease , 1991, Neurology.
[58] H. Osmond-Clarke. Colles's Fracture , 1951 .
[59] N. Quinn,et al. Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations , 2001, Neurology.
[60] R. Armstrong,et al. Parkinson's disease and the eye. , 1997, Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians.
[61] H. Shibasaki,et al. Oculomotor abnormalities in Parkinson's disease. , 1979, Archives of neurology.
[62] S. Leurgans,et al. Progressive worsening of spatial and chromatic processing deficits in Parkinson disease. , 2002, Archives of neurology.
[63] H. Przuntek,et al. Disturbance of colour perception in Parkinson's disease , 1993, Journal of neural transmission. Parkinson's disease and dementia section.
[64] O. Blin,et al. Dopaminergic modulation of visual sensitivity in man , 1993, Fundamental & clinical pharmacology.
[65] N. Accornero,et al. Color VEPs in Parkinson's disease. , 1994, Electroencephalography and clinical neurophysiology.
[66] Christian Haass,et al. Pathological properties of the Parkinson’s disease-associated protein DJ-1 in α-synucleinopathies and tauopathies: relevance for multiple system atrophy and Pick’s disease , 2004, Acta Neuropathologica.
[67] Akiko Tamura,et al. Impaired Visual Acuity as a Risk Factor for Visual Hallucinations in Parkinson’s Disease , 2006, Journal of geriatric psychiatry and neurology.
[68] J. S. Liu,et al. The validity of eye blink rate in Chinese adults for the diagnosis of Parkinson's disease , 2003, Clinical Neurology and Neurosurgery.
[69] L. Illis,et al. BRAIN'S DISEASES OF THE NERVOUS SYSTEM , 2002, Spinal Cord.
[70] R. Feldman,et al. Abnormalities in color vision and contrast sensitivity in Parkinson's disease , 1992, Neurology.